Form: 10-K

Annual report pursuant to Section 13 and 15(d)

June 21, 2024

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the registration statements (Nos. 333-191383, 333-227476 and 333-274228) on Form S-8 and (No. 333-274899) on Form S-3 of our report dated June 21, 2024, with respect to the consolidated financial statements of Acasti Pharma Inc.

 

/s/ KPMG LLP

 

Philadelphia, Pennsylvania
June 21, 2024